FDA 483 - Biocon Biosphere Limited - November 07, 2025
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Biocon Biosphere Limited, a drug substance manufacturer, was inspected and cited for two significant observations. The firm failed to establish appropriate qualifications and controls for computerized systems, specifically regarding the validation and control of electronic master batch records. Additionally, written procedures for equipment cleaning were found to be inadequately described or followed, with cleaning limits lacking scientific justification and deficiencies in swab sampling methods.
ID · 303b1312-0294-4597-88e2-3746045dfd99